In-vitro activity of antibiotics against Legionella pneumophila isolates from water systems

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 5, 1999, Pages 693-695

  Tsakris, A ^a   Alexiou Daniel, S ^a   Souliou, E ^a   Antoniadis, A ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; PEFLOXACIN; RIFAMPICIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; LEGIONELLA PNEUMOPHILA; NONHUMAN; WATER SUPPLY;

ANTI-BACTERIAL AGENTS; EUROPE; LEGIONELLA PNEUMOPHILA; MICROBIAL SENSITIVITY TESTS; WATER MICROBIOLOGY; WATER SUPPLY;

EID: 0032760249     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.5.693     Document Type: Article

References (10)

1. Marrie, T. J. (1993). Community-acquired Legionnaires' disease: a reassessment. In Legionella: Current Status and Emerging Perspectives (Barbaree, J. M., Breiman, R. F. & Dufour, A. P., Eds), pp. 46-7. American Society for Microbiology, Washington, DC.
2. Edelstein, P. H. (1995). Antimicrobial chemotherapy for Legionnaires' disease: a review. Clinical Infectious Diseases 21, Suppl. 3, S265-76.
3. Unertl, K. E., Lenhart, F. P., Forst, H., Vogler, G., Wilm, V., Ehret, W. et al. (1989). Ciprofloxacin in the treatment of legionellosis in critically ill patients including those cases unresponsive to erythromycin. American Journal of Medicine 87, Suppl. 5A, S128-31.
4. Onody, C., Matsiota-Bernard, P. & Nauciel, C. (1997). Lack of resistance to erythromycin, rifampicin and ciprofloxacin in 98 clinical isolates of Legionella pneumophila. Journal of Antimicrobial Chemotherapy 39, 816-6.
5. Baltch, A. L., Smith, R. P. & Ritz, W. (1995). Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampicin used singly and in combination against Legionella pneumophila. Antimicrobial Agents and Chemotherapy 39, 1661-6.
6. Moffie, B. G. & Mouton, R. P. (1988). Sensitivity and resistance of Legionella pneumophila to some antibiotics and combinations of antibiotics. Journal of Antimicrobial Chemotherapy 22, 457-62.
7. Johnson, D. M., Erwin, M. E., Barret, M. S., Gooding, B. B. & Jones, R. N. (1992). Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella species. European Journal of Clinical Microbiology and Infectious Diseases 11, 751-5.
8. Pendland, S. L., Killian, A. D., Woodward, J. G. & Rodvold, K. A. (1997). In-vitro activity of a new oral streptogramin, RPR 106972, alone and in combination with rifampicin or ciprofloxacin against Legionella spp. Journal of Antimicrobial Chemotherapy 39, 651-3.
9. Reda, C., Quaresima, T. & Castellani Pastoris, M. C. (1994). In-vitro activity of six intracellular antibiotics against Legionella pneumophila strains of human and environmental origin. Journal of Antimicrobial Chemotherapy 33, 757-64.
10. Bornstein, N., Roudier, C. & Fleurette, J. (1985). Determination of the activity on Legionella of eight macrolids and related agents by comparative testing on three media. Journal of Antimicrobial Chemotherapy 15, 17-22.